सामग्री पर जाएँ

दवाओं की अंतःक्रिया

Enzalutamide + Mavacamten

गंभीरता: निषिद्ध

Enzalutamide and Mavacamten: contraindicated interaction.

अंतिम अपडेट

केवल स्वास्थ्य पेशेवरों के लिए — मात्र संदर्भ हेतु। यह पृष्ठ संक्षिप्त सारांश है, चिकित्सकीय सलाह नहीं है और आधिकारिक लेबल या नैदानिक निर्णय का विकल्प नहीं है। दवा लिखने या देने से पहले हमेशा जाँच करें।

इस पृष्ठ की नैदानिक सामग्री केवल अंग्रेज़ी में उपलब्ध है।

सारांश

Mavacamten is cleared by CYP2C19 and CYP3A4, and enzalutamide induces both, lowering exposure and reducing therapeutic effect on outflow obstruction. Labeling advises against use with strong inducers of these enzymes.

इस इंटरैक्शन का सरल भाषा में अर्थ

Enzalutamide and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two.

Enzalutamide belongs to Endocrine; Mavacamten belongs to Cardiovascular.

साक्ष्य स्तर: Moderate

ऐसा क्यों होता है

Induction of CYP2C19 and CYP3A4 by enzalutamide increases mavacamten clearance.

क्या करें

Avoid the combination; if enzalutamide is started or stopped in a mavacamten patient, check LVEF and gradient by echocardiography and adjust the dose.

फार्मासिस्ट से क्या पूछें

  • Is there an alternative to one of these two medicines for me?
  • If both are essential, who is monitoring me and how often?
  • Which symptoms mean I should stop and seek help straight away?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ सदस्यों के लिए

पूरा पेज खोलें

Enzalutamide और Mavacamten की पूरी प्रबंधन सलाह, अतिरिक्त नोट्स, साक्ष्य का विवरण और पूरे पर्चे का इंटरैक्शन चेकर खोलने के लिए खाता बनाएँ और Pro+ ट्रायल शुरू करें।

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

वेब पर Pro+ को 14 दिन मुफ़्त आज़माएँ। कार्ड की ज़रूरत नहीं।

अक्सर पूछे जाने वाले प्रश्न

Can I take Enzalutamide with Mavacamten?

MediHelp rates the interaction as contraindicated. Enzalutamide and Mavacamten are not normally used together. Taking them at the same time is expected to cause harm or make one of them unsafe, so a different medicine is usually chosen for one of the two. Mavacamten is cleared by CYP2C19 and CYP3A4, and enzalutamide induces both, lowering exposure and reducing therapeutic effect on outflow obstruction. Labeling advises against use with strong inducers of these enzymes.

How serious is the interaction between Enzalutamide and Mavacamten?

MediHelp rates it contraindicated, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; if enzalutamide is started or stopped in a mavacamten patient, check LVEF and gradient by echocardiography and adjust the dose.

What other medicines interact with Enzalutamide?

MediHelp also lists interactions of Enzalutamide with, for example, Doravirine, Elbasvir / grazoprevir, Ensitrelvir. The full list is on the Enzalutamide page.

MediHelp ऐप में पूर्ण मोनोग्राफ़, खुराक और इंटरैक्शन चेकर

MediHelp ऐप में पूरा संदर्भ खोलें, कई दवाओं की अंतःक्रियाएँ जाँचें और खुराक टूल इस्तेमाल करें।

A–Z ब्राउज़ करें · दवाओं की अंतःक्रिया

ऐप पाएँ साइन इन